Mads Thomassen

4PUBLICATIONS
55CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 04, 2025
Monitoring ctDNA in aggressive B-cell lymphoma: a prospective correlative study of ctDNA kinetics and PET-CT metrics.

Gayaththri Vimalathas, Marcus Høy Hansen, Oriane Cédile

|Jun 04, 2025
Aortic Aneurysm Risk and the Somatic JAK2 V617F Mutation: Insights From a Multicenter, Population-Based Cardiovascular Screening Study.

Lasse M Obel, Joachim S Skovbo, Axel C P Diederichsen

|May 23, 2025
Timely germline BRCA testing after invasive breast cancer promotes contralateral risk-reducing mastectomy and improves survival: an observational retrospective study.

Aleksandar M Kostov, Maj-Britt Jensen, Bent Ejlertsen

|Aug 18, 2022
Clinical, splicing, and functional analysis to classify BRCA2 exon 3 variants: Application of a points-based ACMG/AMP approach.

Mads Thomassen, Romy L S Mesman, Thomas V O Hansen

Pageof 1

Frequent Collaborators

1 joint publications

Romy L S Mesman

1 joint publications

Emma Tudini

1 joint publications

Michael T Parsons

1 joint publications

Brage S Andresen